Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-25-019712
Filing Date
2025-06-06
Accepted
2025-06-06 16:02:31
Documents
9
Effectiveness Date
2025-06-06

Document Format Files

Seq Description Document Type Size
1 FORM S-8 govx20250602_s8.htm S-8 62650
2 EXHIBIT 5.1 ex_826676.htm EX-5.1 10807
3 EXHIBIT 23.1 ex_826124.htm EX-23.1 2651
4 EXHIBIT 99.1 ex_826125.htm EX-99.1 190707
5 EXHIBIT FILING FEES ex_826126.htm EX-FILING FEES 25266
6 wbd01.jpg GRAPHIC 3814
7 wbd02.jpg GRAPHIC 16312
8 wbd03.jpg GRAPHIC 7537
9 wbd04.jpg GRAPHIC 5094
  Complete submission text file 0001437749-25-019712.txt   338943
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287840 | Film No.: 251030461
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)